Fulcrum Therapeutics Ownership 2024 | Who Owns Fulcrum Therapeutics Now?
Institutional Ownership
103.74%
Insider Ownership
1.62%
Retail Ownership
-5.36%
Institutional Holders
130.00
Fulcrum Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 18.73% | 0.95% | 11,609,704 | - | - | 71,980,165 | Jun 30, 2024 |
| RTW INVESTMENTS, LP | 9.43% | 0.56% | 5,845,956 | - | - | 36,244,927 | Jun 30, 2024 |
| FMR LLC | 8.60% | 0.00% | 5,329,946 | -34,719 | -0.65% | 33,045,666 | Jun 30, 2024 |
| BLACKROCK INC. | 7.74% | 0.00% | 4,798,522 | 3,257,313 | 211.35% | 29,750,836 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.95% | 0.00% | 3,071,143 | 532,478 | 20.97% | 19,041,086 | Jun 30, 2024 |
| COWEN AND COMPANY, LLC | 4.78% | 0.51% | 2,964,127 | -749,807 | -20.19% | 18,377,586 | Jun 30, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4.10% | 0.58% | 2,541,046 | -307,440 | -10.79% | 15,754,485 | Jun 30, 2024 |
| TRV GP IV, LLC | 3.78% | 7.18% | 2,343,154 | - | - | 14,527,555 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 3.36% | 0.20% | 2,084,700 | 706,200 | 51.23% | 12,925,140 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 2.42% | 0.76% | 1,500,000 | 500,000 | 50.00% | 9,300,000 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 2.39% | 0.00% | 1,480,926 | 176,114 | 13.50% | 9,182,168 | Jun 30, 2024 |
| BIOIMPACT CAPITAL LLC | 2.33% | 1.39% | 1,444,851 | 307,743 | 27.06% | 8,958,076 | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | 2.31% | 0.09% | 1,433,316 | 281,590 | 24.45% | 8,886,559 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.11% | 0.00% | 1,307,377 | 743,919 | 132.03% | 8,107,443 | Jun 30, 2024 |
| MORGAN STANLEY | 1.99% | 0.00% | 1,234,813 | 77,676 | 6.71% | 7,655,841 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 1.87% | 0.54% | 1,160,000 | 465,000 | 66.91% | 7,192,000 | Jun 30, 2024 |
| STATE STREET CORP | 1.68% | 0.00% | 1,041,274 | 784,413 | 305.38% | 6,455,899,000 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 1.37% | 0.00% | 849,193 | 26,095 | 3.17% | 5,264,997 | Jun 30, 2024 |
| PROPEL BIO MANAGEMENT, LLC | 1.21% | 3.02% | 750,000 | - | - | 4,650,000 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 1.17% | 0.14% | 727,673 | - | - | 4,511,573 | Jun 30, 2024 |
Fulcrum Therapeutics's largest institutional shareholder is RA CAPITAL MANAGEMENT, L.P., holding 18.73% of the company's total share outstanding, currently valued at $71.98M. The top 10 institutional shareholders own together 67.90% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TRV GP IV, LLC | 3.78% | 7.18% | 2,343,154 | - | - | 14,527,555 | Jun 30, 2024 |
| MASS GENERAL BRIGHAM, INC | 0.33% | 6.20% | 205,356 | - | - | 1,273,207 | Jun 30, 2024 |
| PROPEL BIO MANAGEMENT, LLC | 1.21% | 3.02% | 750,000 | - | - | 4,650,000 | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | 0.49% | 1.63% | 302,700 | 302,700 | 100.00% | 1,876,740 | Jun 30, 2024 |
| BIOIMPACT CAPITAL LLC | 2.33% | 1.39% | 1,444,851 | 307,743 | 27.06% | 8,958,076 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 1.12% | 1.27% | 696,464 | 289,356 | 71.08% | 4,318,077 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 18.73% | 0.95% | 11,609,704 | - | - | 71,980,165 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 2.42% | 0.76% | 1,500,000 | 500,000 | 50.00% | 9,300,000 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0.64% | 0.58% | 398,436 | - | - | 2,470,303 | Jun 30, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4.10% | 0.58% | 2,541,046 | -307,440 | -10.79% | 15,754,485 | Jun 30, 2024 |
| RTW INVESTMENTS, LP | 9.43% | 0.56% | 5,845,956 | - | - | 36,244,927 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 1.87% | 0.54% | 1,160,000 | 465,000 | 66.91% | 7,192,000 | Jun 30, 2024 |
| COWEN AND COMPANY, LLC | 4.78% | 0.51% | 2,964,127 | -749,807 | -20.19% | 18,377,586 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.59% | 0.43% | 368,369 | 28,544 | 8.40% | 2,283,888 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 0.46% | 0.40% | 285,000 | 155,000 | 119.23% | 1,767,000 | Jun 30, 2024 |
| SIMPLIFY ASSET MANAGEMENT INC. | 1.09% | 0.28% | 674,832 | -1,199 | -0.18% | 4,183,958 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 3.36% | 0.20% | 2,084,700 | 706,200 | 51.23% | 12,925,140 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.40% | 0.18% | 250,000 | -25,000 | -9.09% | 1,550,000 | Jun 30, 2024 |
| BRANDYWINE MANAGERS, LLC | 0.04% | 0.17% | 26,127 | - | - | 161,987 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 1.17% | 0.14% | 727,673 | - | - | 4,511,573 | Jun 30, 2024 |
The largest Fulcrum Therapeutics shareholder by % of total assets is TRV GP IV, LLC. The company owns 2.34M shares of Fulcrum Therapeutics (FULC), representing 7.18% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 7.74% | 0.00% | 4,798,522 | 3,257,313 | 211.35% | 29,750,836 | Jun 30, 2024 |
| STATE STREET CORP | 1.68% | 0.00% | 1,041,274 | 784,413 | 305.38% | 6,455,899,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.11% | 0.00% | 1,307,377 | 743,919 | 132.03% | 8,107,443 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 3.36% | 0.20% | 2,084,700 | 706,200 | 51.23% | 12,925,140 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.95% | 0.00% | 3,071,143 | 532,478 | 20.97% | 19,041,086 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.81% | 0.03% | 501,301 | 501,301 | 100.00% | 3,108,066 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 2.42% | 0.76% | 1,500,000 | 500,000 | 50.00% | 9,300,000 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 0.80% | 0.01% | 497,456 | 497,456 | 100.00% | 3,084,227 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 1.87% | 0.54% | 1,160,000 | 465,000 | 66.91% | 7,192,000 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.82% | 0.01% | 509,688 | 334,464 | 190.88% | 3,160,066 | Jun 30, 2024 |
| BIOIMPACT CAPITAL LLC | 2.33% | 1.39% | 1,444,851 | 307,743 | 27.06% | 8,958,076 | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | 0.49% | 1.63% | 302,700 | 302,700 | 100.00% | 1,876,740 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 1.12% | 1.27% | 696,464 | 289,356 | 71.08% | 4,318,077 | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | 2.31% | 0.09% | 1,433,316 | 281,590 | 24.45% | 8,886,559 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.85% | 0.05% | 525,300 | 209,840 | 66.52% | 3,256,860 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.30% | 0.00% | 186,727 | 186,727 | 100.00% | 1,157,707 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 2.39% | 0.00% | 1,480,926 | 176,114 | 13.50% | 9,182,168 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.27% | 0.00% | 169,549 | 169,549 | 100.00% | 1,051,204 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 0.46% | 0.40% | 285,000 | 155,000 | 119.23% | 1,767,000 | Jun 30, 2024 |
| EVERSEPT PARTNERS, LP | 0.25% | 0.06% | 152,965 | 152,965 | 100.00% | 948,383 | Jun 30, 2024 |
As of Jun 30 2024, Fulcrum Therapeutics's largest institutional buyer is BLACKROCK INC.. The company purchased 3.26M stocks of FULC, valued at $29.75M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 0.48% | 0.00% | 300,000 | -806,422 | -72.89% | 1,860,000 | Jun 30, 2024 |
| COWEN AND COMPANY, LLC | 4.78% | 0.51% | 2,964,127 | -749,807 | -20.19% | 18,377,586 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | - | - | - | -550,339 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.65% | 0.00% | 402,749 | -494,712 | -55.12% | 2,497,044 | Jun 30, 2024 |
| INVESCO LTD. | 0.05% | - | 31,043 | -465,636 | -93.75% | 192,466 | Jun 30, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4.10% | 0.58% | 2,541,046 | -307,440 | -10.79% | 15,754,485 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.90% | 0.00% | 560,492 | -249,778 | -30.83% | 3,475,050 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -223,400 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -171,507 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.89% | 0.01% | 553,307 | -169,856 | -23.49% | 3,430,504 | Jun 30, 2024 |
| CIBC WORLD MARKETS CORP | - | - | - | -150,000 | -100.00% | - | Jun 30, 2024 |
| HSBC HOLDINGS PLC | - | - | - | -149,627 | -100.00% | - | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | - | - | - | -144,721 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.05% | - | 33,041 | -125,894 | -79.21% | 204,854 | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -123,408 | -100.00% | - | Jun 30, 2024 |
| MAN GROUP PLC | - | - | - | -102,226 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -89,547 | -100.00% | - | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | - | - | - | -88,564 | -100.00% | - | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -88,483 | -100.00% | - | Jun 30, 2024 |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 0.13% | 0.02% | 81,217 | -87,558 | -51.88% | 503,545 | Jun 30, 2024 |
As of Jun 30 2024, Fulcrum Therapeutics's biggest institutional seller is ADAGE CAPITAL PARTNERS GP, L.L.C.. The company sold -0.81M shares of FULC, valued at $1.86M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WOODLINE PARTNERS LP | 0.81% | 0.03% | 501,301 | 501,301 | 100.00% | 3,108,066 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 0.80% | 0.01% | 497,456 | 497,456 | 100.00% | 3,084,227 | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | 0.49% | 1.63% | 302,700 | 302,700 | 100.00% | 1,876,740 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.27% | 0.00% | 169,549 | 169,549 | 100.00% | 1,051,204 | Jun 30, 2024 |
| EVERSEPT PARTNERS, LP | 0.25% | 0.06% | 152,965 | 152,965 | 100.00% | 948,383 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.10% | 0.06% | 59,983 | 59,983 | 100.00% | 371,895 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.10% | 0.05% | 59,000 | 59,000 | 100.00% | 365,800 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 33,383 | 33,383 | 100.00% | 207,308 | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.05% | 0.01% | 28,100 | 28,100 | 100.00% | 174,220 | Jun 30, 2024 |
| SEMANTEON CAPITAL MANAGEMENT, LP | 0.04% | 0.12% | 26,658 | 26,658 | 100.00% | 165,280 | Jun 30, 2024 |
| QUEST PARTNERS LLC | 0.04% | 0.02% | 26,164 | 26,164 | 100.00% | 162,217 | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.04% | 0.00% | 25,100 | 25,100 | 100.00% | 156,000 | Jun 30, 2024 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 0.04% | 0.00% | 24,480 | 24,480 | 100.00% | 151,776 | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | 0.03% | 0.00% | 21,154 | 21,154 | 100.00% | 131,155 | Jun 30, 2024 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 0.03% | 0.00% | 21,038 | 21,038 | 100.00% | 130,436 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.03% | 0.02% | 20,000 | 20,000 | 100.00% | 124,000 | Jun 30, 2024 |
| ENGINEERS GATE MANAGER LP | 0.03% | 0.00% | 19,860 | 19,860 | 100.00% | 123,132 | Jun 30, 2024 |
| AIGEN INVESTMENT MANAGEMENT, LP | 0.03% | 0.02% | 19,311 | 19,311 | 100.00% | 119,728 | Jun 30, 2024 |
| CAXTON ASSOCIATES LP | 0.03% | 0.00% | 18,875 | 18,875 | 100.00% | 117,025 | Jun 30, 2024 |
| METLIFE INVESTMENT MANAGEMENT, LLC | 0.03% | 0.00% | 15,898 | 15,898 | 100.00% | 98,568 | Jun 30, 2024 |
| QUANTBOT TECHNOLOGIES LP | 0.02% | 0.00% | 14,029 | 14,029 | 100.00% | 86,980 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.02% | 0.00% | 13,257 | 13,257 | 100.00% | 82,193 | Jun 30, 2024 |
| WOLVERINE TRADING, LLC | 0.02% | 0.00% | 12,700 | 12,700 | 100.00% | 78,740 | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | 0.02% | 0.04% | 11,606 | 11,606 | 100.00% | 71,957 | Jun 30, 2024 |
| BELVEDERE TRADING LLC | 0.02% | 0.00% | 11,300 | 11,300 | 100.00% | 70,060 | Jun 30, 2024 |
| PROFUND ADVISORS LLC | 0.02% | 0.00% | 10,921 | 10,921 | 100.00% | 67,710 | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | 0.01% | 0.00% | 6,079 | 6,079 | 100.00% | 37,690 | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | 0.01% | - | 6,000 | 6,000 | 100.00% | 37,290 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.01% | - | 5,944 | 5,944 | 100.00% | 37,000 | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 0.01% | - | 4,496 | 4,496 | 100.00% | 27,875 | Jun 30, 2024 |
| BELVEDERE TRADING LLC | 0.01% | - | 3,988 | 3,988 | 100.00% | 24,726 | Jun 30, 2024 |
| AMALGAMATED BANK | 0.00% | 0.00% | 2,147 | 2,147 | 100.00% | 13,000 | Jun 30, 2024 |
| COWEN AND COMPANY, LLC | 0.00% | - | 1,300 | 1,300 | 100.00% | 650 | Jun 30, 2024 |
| HARBOUR INVESTMENTS, INC. | 0.00% | 0.00% | 1,165 | 1,165 | 100.00% | 7,223 | Jun 30, 2024 |
| ROTHSCHILD INVESTMENT LLC | - | - | 20 | 20 | 100.00% | 124 | Jun 30, 2024 |
Fulcrum Therapeutics's largest new institutional shareholder by number of shares is WOODLINE PARTNERS LP, purchased 501.30K shares, valued at $3.11M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AFFINITY ASSET ADVISORS, LLC | - | - | - | -550,339 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -223,400 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -171,507 | -100.00% | - | Jun 30, 2024 |
| CIBC WORLD MARKETS CORP | - | - | - | -150,000 | -100.00% | - | Jun 30, 2024 |
| HSBC HOLDINGS PLC | - | - | - | -149,627 | -100.00% | - | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | - | - | - | -144,721 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -123,408 | -100.00% | - | Jun 30, 2024 |
| MAN GROUP PLC | - | - | - | -102,226 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -89,547 | -100.00% | - | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | - | - | - | -88,564 | -100.00% | - | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -88,483 | -100.00% | - | Jun 30, 2024 |
| GILDER GAGNON HOWE & CO LLC | - | - | - | -65,600 | -100.00% | - | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -54,416 | -100.00% | - | Jun 30, 2024 |
| PDT PARTNERS, LLC | - | - | - | -49,518 | -100.00% | - | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | - | - | - | -43,080 | -100.00% | - | Jun 30, 2024 |
| ACUITAS INVESTMENTS, LLC | - | - | - | -33,224 | -100.00% | - | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | - | - | - | -29,169 | -100.00% | - | Jun 30, 2024 |
| DENALI ADVISORS LLC | - | - | - | -27,100 | -100.00% | - | Jun 30, 2024 |
| BROWN WEALTH MANAGEMENT, LLC | - | - | - | -25,000 | -100.00% | - | Jun 30, 2024 |
| WOLVERINE TRADING, LLC | - | - | - | -23,579 | -100.00% | - | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | - | - | - | -20,472 | -100.00% | - | Jun 30, 2024 |
| BLACKSTONE INC. | - | - | - | -19,216 | -100.00% | - | Jun 30, 2024 |
| POLYMER CAPITAL MANAGEMENT (HK) LTD | - | - | - | -18,874 | -100.00% | - | Jun 30, 2024 |
| LMR PARTNERS LLP | - | - | - | -17,539 | -100.00% | - | Jun 30, 2024 |
| PRINCIPAL FINANCIAL GROUP INC | - | - | - | -16,233 | -100.00% | - | Jun 30, 2024 |
| CTC ALTERNATIVE STRATEGIES, LTD. | - | - | - | -14,700 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -13,154 | -100.00% | - | Jun 30, 2024 |
| ATOM INVESTORS LP | - | - | - | -12,658 | -100.00% | - | Jun 30, 2024 |
| CAPSTONE INVESTMENT ADVISORS, LLC | - | - | - | -10,900 | -100.00% | - | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | - | - | - | -10,600 | -100.00% | - | Jun 30, 2024 |
| FERNWOOD INVESTMENT MANAGEMENT, LLC | - | - | - | -7,613 | -100.00% | - | Jun 30, 2024 |
| MARQUETTE ASSET MANAGEMENT, LLC | - | - | - | -6,039 | -100.00% | - | Jun 30, 2024 |
| MACQUARIE GROUP LTD | - | - | - | -4,365 | -100.00% | - | Jun 30, 2024 |
| QUADRANT CAPITAL GROUP LLC | - | - | - | -1,038 | -100.00% | - | Jun 30, 2024 |
| GAMMA INVESTING LLC | - | - | - | -45 | -100.00% | - | Jun 30, 2024 |
Fulcrum Therapeutics's largest sold out institutional shareholder by shares sold is AFFINITY ASSET ADVISORS, LLC, sold -0.55M shares, valued at -, as of undefined.
Fulcrum Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| TEKLA LIFE SCIENCES INVESTORS | 0.54% | 256,888 | - | - | Mar 31, 2024 |
| CORNERCAP GROUP OF FUNDS /VA/ | 0.18% | 13,071 | - | - | Sep 30, 2022 |
| FIDELITY ADVISOR SERIES VII | 0.09% | 778,000 | - | - | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.08% | 42,012 | - | - | Mar 31, 2024 |
| ALGER PORTFOLIOS | 0.06% | 21,756 | - | - | Dec 31, 2023 |
| FIDELITY MT VERNON STREET TRUST | 0.06% | 1,613,092 | -84,576 | -4.98% | Feb 29, 2024 |
| BRIDGEWAY FUNDS INC | 0.04% | 88,564 | -37,936 | -29.99% | Mar 28, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.03% | 2,026,155 | -294,242 | -12.68% | Feb 29, 2024 |
| ALGER INSTITUTIONAL FUNDS | 0.03% | 6,518 | - | - | Jan 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.02% | 253,100 | - | - | Jan 31, 2024 |
| FORUM FUNDS II | 0.02% | 18,977 | - | - | Jan 31, 2024 |
| ALGER FUNDS | 0.02% | 16,281 | - | - | Jan 31, 2024 |
| LORD ABBETT SECURITIES TRUST | 0.01% | 65,226 | - | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 81,540 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 7,828 | - | - | Mar 31, 2024 |
| Federated Hermes MDT Series | 0.01% | 32,494 | - | - | Jan 31, 2024 |
| Simplify Exchange Traded Funds | 0.01% | 676,031 | 112,706 | 20.01% | Mar 28, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 36,680 | - | - | Feb 29, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.01% | 94,360 | - | - | Mar 28, 2024 |
| Gabelli Healthcare & WellnessRx Trust | 0.01% | 1,000 | - | - | Dec 29, 2023 |
| FIDELITY SECURITIES FUND | 0.01% | 737,000 | - | - | Jan 31, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.01% | 32,400 | -26,400 | -44.90% | Mar 31, 2024 |
| ETFis Series Trust I | 0.01% | 9,496 | - | - | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 2,439,610 | -702,538 | -22.36% | Mar 31, 2024 |
| Nushares ETF Trust | 0.01% | 39,179 | - | - | Jan 31, 2024 |
| ALPS ETF Trust | 0.00% | 43,178 | 2,200 | 5.37% | Feb 29, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 597 | - | - | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 205,410 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 468,980 | 16,686 | 3.69% | Feb 29, 2024 |
| AB VARIABLE PRODUCTS SERIES FUND, INC. | 0.00% | 10,181 | - | - | Mar 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 104,308 | - | - | Feb 29, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 523,145 | 522,048 | 47588.70% | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 43,286 | - | - | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 16,233 | -1,760 | -9.78% | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 38,618 | -2,693 | -6.52% | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 3,342 | - | - | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 22,326 | - | - | Jan 31, 2024 |
| AMG Funds I | 0.00% | 2,219 | - | - | Jan 31, 2024 |
| Managed Portfolio Series | 0.00% | 21,643 | - | - | Jan 31, 2024 |
| Dimensional ETF Trust | 0.00% | 350,767 | 196,201 | 126.94% | Jan 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 17,543 | - | - | Feb 29, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 2,079 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 73,290 | 25,125 | 52.16% | Feb 29, 2024 |
| HC CAPITAL TRUST | 0.00% | 19,751 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 24,485 | - | - | Jan 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 603,625 | 169,647 | 39.09% | Jan 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 135,739 | - | - | Feb 29, 2024 |
| Victory Portfolios II | 0.00% | 26,280 | - | - | Mar 31, 2024 |
| SEASONS SERIES TRUST | 0.00% | 11,983 | - | - | Mar 31, 2024 |
| ProFunds | 0.00% | 3,860 | 3,207 | 491.12% | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 2,976 | 45 | 1.54% | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 118 | - | - | Apr 30, 2021 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,046 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 13,400 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 29,349 | -8,179 | -21.79% | Mar 28, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 454,519 | - | - | Mar 31, 2024 |
| JPMorgan Trust I | 0.00% | 137,307 | - | - | Jan 31, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 12,200 | -400 | -3.17% | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 185,492 | - | - | Feb 29, 2024 |
| Federated Hermes Global Allocation Fund | 0.00% | 843 | - | - | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 345 | - | - | Dec 31, 2023 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 83,439 | - | - | Mar 31, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 2,190 | - | - | Mar 31, 2024 |
| VALIC Co I | 0.00% | 18,988 | - | - | Feb 29, 2024 |
| TIAA-CREF FUNDS | 0.00% | 201,959 | - | - | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 8,512 | - | - | Mar 31, 2024 |
| RBB FUND, INC. | 0.00% | 5,904 | - | - | Feb 29, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 212 | - | - | Dec 31, 2023 |
| PENN SERIES FUNDS INC | 0.00% | 1,500 | - | - | Mar 28, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 6,727 | 6,389 | 1890.24% | Jan 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.00% | 463 | - | - | Mar 31, 2024 |
| PGIM ETF TRUST | 0.00% | 2,506 | - | - | Feb 29, 2024 |
| iSHARES TRUST | 0.00% | 617,004 | 50,804 | 8.97% | Mar 31, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 14,548 | - | - | Feb 29, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 3,685 | - | - | Mar 28, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 7,777 | 1,391 | 21.78% | Jan 31, 2024 |
| FLEXSHARES TRUST | 0.00% | 2,509 | - | - | Jan 31, 2024 |
| THRIVENT MUTUAL FUNDS | 0.00% | 2,737 | - | - | Mar 28, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 2,485 | - | - | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 160 | - | - | Feb 29, 2024 |
| FundVantage Trust | 0.00% | 325 | - | - | Mar 28, 2024 |
| Brighthouse Funds Trust II | 0.00% | 17,766 | - | - | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 4,620 | 677 | 17.17% | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 21 | - | - | Dec 31, 2023 |
| Direxion Shares ETF Trust | 0.00% | 2,405 | - | - | Jan 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 5,911 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,576 | - | - | Feb 29, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 902 | - | - | Feb 29, 2024 |
| Fidelity Rutland Square Trust II | 0.00% | 15,589 | 3,386 | 27.75% | Feb 29, 2024 |
| ADVANCED SERIES TRUST | 0.00% | 26,900 | - | - | Mar 28, 2024 |
| EQ ADVISORS TRUST | 0.00% | 9,511 | -300 | -3.06% | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 165 | - | - | Jan 31, 2024 |
| MUTUAL FUND SERIES TRUST | 0.00% | 28,500 | - | - | Mar 31, 2024 |
| ALLSPRING FUNDS TRUST | 0.00% | 2,498 | - | - | Jan 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 10,042 | - | - | Mar 31, 2024 |
| EMPOWER FUNDS, INC. | 0.00% | 4,164 | - | - | Mar 31, 2024 |
| WILSHIRE MUTUAL FUNDS INC | 0.00% | 1,070 | - | - | Dec 31, 2023 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 10,005 | - | - | Dec 31, 2023 |
| Bridge Builder Trust | 0.00% | 15,311 | - | - | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 9,317 | - | - | Mar 31, 2024 |
Fulcrum Therapeutics's largest mutual fund holder by % of total assets is "TEKLA LIFE SCIENCES INVESTORS", owning 256.89K shares, compromising 0.54% of its total assets.
Fulcrum Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 130 | -3.70% |
| 31 Mar, 24 | 135 | 31.07% |
| 31 Dec, 23 | 103 | 21.18% |
| 30 Sep, 23 | 85 | -6.59% |
| 30 Jun, 23 | 91 | -23.53% |
| 31 Mar, 23 | 119 | 5.31% |
| 31 Dec, 22 | 113 | 4.63% |
| 30 Sep, 22 | 108 | - |
| 30 Jun, 22 | 108 | -4.42% |
| 31 Mar, 22 | 113 | -2.59% |
| 31 Dec, 21 | 116 | 7.41% |
| 30 Sep, 21 | 108 | 61.19% |
| 30 Jun, 21 | 67 | -1.47% |
| 31 Mar, 21 | 68 | 3.03% |
| 31 Dec, 20 | 66 | 24.53% |
| 30 Sep, 20 | 53 | -11.67% |
| 30 Jun, 20 | 60 | 27.66% |
| 31 Mar, 20 | 47 | 23.68% |
| 31 Dec, 19 | 38 | -2.56% |
| 30 Sep, 19 | 39 | - |
As of 30 Jun 24, 130 institutions are holding Fulcrum Therapeutics's shares, representing a decrease of -3.70% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 64,304,832 | 6.51% |
| 31 Mar, 24 | 60,375,967 | -0.73% |
| 31 Dec, 23 | 60,818,520 | 7.84% |
| 30 Sep, 23 | 56,394,592 | 1.60% |
| 30 Jun, 23 | 55,508,341 | -8.06% |
| 31 Mar, 23 | 60,372,427 | 19.43% |
| 31 Dec, 22 | 50,551,267 | -3.03% |
| 30 Sep, 22 | 52,130,137 | 29.90% |
| 30 Jun, 22 | 40,129,728 | 1.66% |
| 31 Mar, 22 | 39,474,722 | 6.12% |
| 31 Dec, 21 | 37,199,941 | 1.93% |
| 30 Sep, 21 | 36,494,565 | 36.18% |
| 30 Jun, 21 | 26,798,659 | -0.43% |
| 31 Mar, 21 | 26,913,137 | 21.39% |
| 31 Dec, 20 | 22,170,902 | 7.66% |
| 30 Sep, 20 | 20,593,840 | 0.67% |
| 30 Jun, 20 | 20,456,058 | 21.56% |
| 31 Mar, 20 | 16,827,547 | 6.60% |
| 31 Dec, 19 | 15,784,962 | -0.76% |
| 30 Sep, 19 | 15,906,414 | - |
Fulcrum Therapeutics (FULC) has 64.30M shares outstanding as of 30 Jun 24, up 6.51% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 103.74% | 1.07% |
| 31 Mar, 24 | 98.48% | 1.02% |
| 31 Dec, 23 | 98.38% | 1.18% |
| 30 Sep, 23 | 91.26% | 1.06% |
| 30 Jun, 23 | 92.94% | 0.91% |
| 31 Mar, 23 | 101.09% | 0.80% |
| 31 Dec, 22 | 112.36% | 0.88% |
| 30 Sep, 22 | 112.80% | 1.17% |
| 30 Jun, 22 | 98.14% | 1.04% |
| 31 Mar, 22 | 97.12% | 1.16% |
| 31 Dec, 21 | 91.67% | 0.92% |
| 30 Sep, 21 | 99.70% | 1.48% |
| 30 Jun, 21 | 82.11% | 1.13% |
| 31 Mar, 21 | 85.41% | 1.12% |
| 31 Dec, 20 | 87.45% | 1.53% |
| 30 Sep, 20 | 75.54% | 1.03% |
| 30 Jun, 20 | 85.76% | 1.56% |
| 31 Mar, 20 | 74.07% | 1.52% |
| 31 Dec, 19 | 69.81% | 0.87% |
| 30 Sep, 19 | 89.44% | - |
As of 30 Jun 24, Fulcrum Therapeutics is held by 103.74% institutional shareholders, representing a 1.07% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 77 | 6.94% |
| 31 Mar, 24 | 72 | 41.18% |
| 31 Dec, 23 | 51 | 45.71% |
| 30 Sep, 23 | 35 | -10.26% |
| 30 Jun, 23 | 39 | -51.25% |
| 31 Mar, 23 | 80 | 17.65% |
| 31 Dec, 22 | 68 | 9.68% |
| 30 Sep, 22 | 62 | 1.64% |
| 30 Jun, 22 | 61 | 12.96% |
| 31 Mar, 22 | 54 | -28.00% |
| 31 Dec, 21 | 75 | -3.85% |
| 30 Sep, 21 | 78 | 95.00% |
| 30 Jun, 21 | 40 | 17.65% |
| 31 Mar, 21 | 34 | -12.82% |
| 31 Dec, 20 | 39 | 56.00% |
| 30 Sep, 20 | 25 | -35.90% |
| 30 Jun, 20 | 39 | 8.33% |
| 31 Mar, 20 | 36 | 100.00% |
| 31 Dec, 19 | 18 | -53.85% |
| 30 Sep, 19 | 39 | - |
77 institutional shareholders have increased their position in FULC stock as of 30 Jun 24 compared to 72 in the previous quarter (a 6.94% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 24 | -14.29% |
| 31 Mar, 24 | 28 | 27.27% |
| 31 Dec, 23 | 22 | -12.00% |
| 30 Sep, 23 | 25 | -21.88% |
| 30 Jun, 23 | 32 | 60.00% |
| 31 Mar, 23 | 20 | -23.08% |
| 31 Dec, 22 | 26 | 13.04% |
| 30 Sep, 22 | 23 | 9.52% |
| 30 Jun, 22 | 21 | -43.24% |
| 31 Mar, 22 | 37 | 54.17% |
| 31 Dec, 21 | 24 | 50.00% |
| 30 Sep, 21 | 16 | - |
| 30 Jun, 21 | 16 | - |
| 31 Mar, 21 | 16 | 33.33% |
| 31 Dec, 20 | 12 | - |
| 30 Sep, 20 | 12 | 33.33% |
| 30 Jun, 20 | 9 | 80.00% |
| 31 Mar, 20 | 5 | -54.55% |
| 31 Dec, 19 | 11 | - |
| 30 Sep, 19 | - | - |
24 institutional shareholders have reduced their position in FULC stock as of 30 Jun 24 compared to 28 in the previous quarter (a -14.29% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 130 | -3.70% | 64,304,832 | 6.51% | 103.74% | 1.07% | 77 | 6.94% | 24 | -14.29% |
| 31 Mar, 24 | 135 | 31.07% | 60,375,967 | -0.73% | 98.48% | 1.02% | 72 | 41.18% | 28 | 27.27% |
| 31 Dec, 23 | 103 | 21.18% | 60,818,520 | 7.84% | 98.38% | 1.18% | 51 | 45.71% | 22 | -12.00% |
| 30 Sep, 23 | 85 | -6.59% | 56,394,592 | 1.60% | 91.26% | 1.06% | 35 | -10.26% | 25 | -21.88% |
| 30 Jun, 23 | 91 | -23.53% | 55,508,341 | -8.06% | 92.94% | 0.91% | 39 | -51.25% | 32 | 60.00% |
| 31 Mar, 23 | 119 | 5.31% | 60,372,427 | 19.43% | 101.09% | 0.80% | 80 | 17.65% | 20 | -23.08% |
| 31 Dec, 22 | 113 | 4.63% | 50,551,267 | -3.03% | 112.36% | 0.88% | 68 | 9.68% | 26 | 13.04% |
| 30 Sep, 22 | 108 | - | 52,130,137 | 29.90% | 112.80% | 1.17% | 62 | 1.64% | 23 | 9.52% |
| 30 Jun, 22 | 108 | -4.42% | 40,129,728 | 1.66% | 98.14% | 1.04% | 61 | 12.96% | 21 | -43.24% |
| 31 Mar, 22 | 113 | -2.59% | 39,474,722 | 6.12% | 97.12% | 1.16% | 54 | -28.00% | 37 | 54.17% |
| 31 Dec, 21 | 116 | 7.41% | 37,199,941 | 1.93% | 91.67% | 0.92% | 75 | -3.85% | 24 | 50.00% |
| 30 Sep, 21 | 108 | 61.19% | 36,494,565 | 36.18% | 99.70% | 1.48% | 78 | 95.00% | 16 | - |
| 30 Jun, 21 | 67 | -1.47% | 26,798,659 | -0.43% | 82.11% | 1.13% | 40 | 17.65% | 16 | - |
| 31 Mar, 21 | 68 | 3.03% | 26,913,137 | 21.39% | 85.41% | 1.12% | 34 | -12.82% | 16 | 33.33% |
| 31 Dec, 20 | 66 | 24.53% | 22,170,902 | 7.66% | 87.45% | 1.53% | 39 | 56.00% | 12 | - |
| 30 Sep, 20 | 53 | -11.67% | 20,593,840 | 0.67% | 75.54% | 1.03% | 25 | -35.90% | 12 | 33.33% |
| 30 Jun, 20 | 60 | 27.66% | 20,456,058 | 21.56% | 85.76% | 1.56% | 39 | 8.33% | 9 | 80.00% |
| 31 Mar, 20 | 47 | 23.68% | 16,827,547 | 6.60% | 74.07% | 1.52% | 36 | 100.00% | 5 | -54.55% |
| 31 Dec, 19 | 38 | -2.56% | 15,784,962 | -0.76% | 69.81% | 0.87% | 18 | -53.85% | 11 | - |
| 30 Sep, 19 | 39 | - | 15,906,414 | - | 89.44% | - | 39 | - | - | - |
Fulcrum Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Fulcrum Therapeutics's stock was made by Sapir Alex on Jul 08 2024, selling 150,000 shares at $3.27 per share (valued at $490.50K). The last insider buy of FULC was made by Sapir Alex on Mar 05 2024, buying 43,360 shares at $11.35 per share (worth $492.03K).
Fulcrum Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 8 | 2 | 400.00% |
| Q1 2024 | 7 | 2 | 350.00% |
| Q3 2023 | 1 | 2 | 50.00% |
| Q2 2023 | 9 | 1 | 900.00% |
| Q1 2023 | 7 | 1 | 700.00% |
| Q4 2022 | 6 | 2 | 300.00% |
| Q3 2022 | 4 | 3 | 133.33% |
| Q2 2022 | 13 | 8 | 162.50% |
| Q1 2022 | 6 | 8 | 75.00% |
| Q4 2021 | 1 | 3 | 33.33% |
| Q3 2021 | 4 | 10 | 40.00% |
| Q2 2021 | 12 | 1 | 1200.00% |
| Q1 2021 | 6 | 13 | 46.15% |
| Q4 2020 | 2 | 1 | 200.00% |
| Q3 2020 | 2 | 5 | 40.00% |
| Q2 2020 | 18 | 37 | 48.65% |
| Q1 2020 | 7 | 12 | 58.33% |
| Q3 2019 | 25 | 29 | 86.21% |
8 total buy trades, and 2 total sell trades (buy/sell ratio of 4.00%) were made by Fulcrum Therapeutics's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | 1 | - |
| Q1 2024 | 1 | 1 | 100.00% |
| Q3 2023 | - | - | - |
| Q2 2023 | - | 1 | - |
| Q1 2023 | 3 | 1 | 300.00% |
| Q4 2022 | 5 | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | 4 | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | 4 | - |
| Q2 2021 | 4 | - | - |
| Q1 2021 | - | 7 | - |
| Q4 2020 | - | - | - |
| Q3 2020 | - | 3 | - |
| Q2 2020 | - | 24 | - |
| Q1 2020 | - | 10 | - |
| Q3 2019 | 8 | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 1 open market sell trades of Fulcrum Therapeutics's stocks.
FULC Ownership FAQ
Who Owns Fulcrum Therapeutics?
Fulcrum Therapeutics is owned by institutional shareholders (103.74%), insiders (1.62%), and public (-5.36%). The largest institutional shareholder of Fulcrum Therapeutics is RA CAPITAL MANAGEMENT, L.P. (18.73% of total shares) and the top mutual fund owner is TEKLA LIFE SCIENCES INVESTORS (0.54% of total shares).
Who are the major institutional shareholders of Fulcrum Therapeutics?
Fulcrum Therapeutics's major institutional shareholders are RA CAPITAL MANAGEMENT, L.P., RTW INVESTMENTS, LP, FMR LLC, BLACKROCK INC., and VANGUARD GROUP INC. The top five shareholders own together 49.46% of the company's share outstanding.
How many Fulcrum Therapeutics shareholders are there?
As of Jun 2024, there are 130 institutional shareholders of Fulcrum Therapeutics.
What percentage of Fulcrum Therapeutics is owned by RA CAPITAL MANAGEMENT, L.P?
RA CAPITAL MANAGEMENT, L.P owns 11.61M shares of Fulcrum Therapeutics, representing 18.73% of the company's total shares outstanding, valued at $71.98M (as of Jun 2024).
What percentage of Fulcrum Therapeutics is owned by RTW INVESTMENTS, LP?
As of Jun 2024, RTW INVESTMENTS, LP holds 5.85M shares of Fulcrum Therapeutics (FULC), compromising 9.43% of the company, valued at $36.24M.
What percentage of Fulcrum Therapeutics is owned by FMR LLC?
FMR LLC is the third largest holder of Fulcrum Therapeutics. The company owns 5.33M of the company's shares outstanding (worth $33.05M).